Targeting Nanotechnologies for the Treatment of Thrombosis and Cardiovascular Disease.

Palazzolo, Jason Sam; Westein, Erik; Hagemeyer, Christoph Eugen; Wang, Ting-Yi

Palazzolo, Jason Sam; Westein, Erik; Hagemeyer, Christoph Eugen; Wang, Ting-Yi.

Afiliación

Palazzolo JS; NanoBiotechnology Laboratory, Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Westein E; NanoBiotechnology Laboratory, Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Hagemeyer CE; NanoBiotechnology Laboratory, Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Wang TY; NanoBiotechnology Laboratory, Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne, Victoria, Australia.

Semin Thromb Hemost ; 46(5): 606-621, 2020 Jul.

Article en En | MEDLINE | ID: mdl-31614390

Asunto(s)

Enfermedades Cardiovasculares/tratamiento farmacológico; Nanotecnología/métodos; Trombosis/terapia; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trombosis / Enfermedades Cardiovasculares / Nanotecnología Límite: Humans Idioma: En Revista: Semin Thromb Hemost Año: 2020 Tipo del documento: Article País de afiliación: Australia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google